Our CEO, Jeffrey Stein, Ph.D., was featured in the latest Scrip Asks issue discussing the need for innovative therapies to effectively treat multiple #influenza strains, including those with pandemic potential like #H5N1. Read more: https://t.co/dL7rLa4LCt
We are pleased to announce the appointment of Frank Karbe as Chief Financial Officer. He brings over 25 years of experience as a strategic financial leader, and we look forward to his contributions to the company. Read more about Mr. Karbe here: https://t.co/HjkZaPqFsA